172
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Flow, compressive, and bioadhesive properties of various blends of poly(ethylene oxide)

, &
Pages 45-55 | Received 15 Feb 2009, Accepted 12 May 2009, Published online: 08 Jan 2010

References

  • Carson JW, Pittenger BH. (1998). Bulk properties of powders. In: Eisen WB, ed. ASM handbook vol. 7—powder metal technologies and applications. Materials Park, OH: ASM International, 287–301.
  • Amidon GE. (1999). Physical test methods for powder flow characterization of pharmaceutical materials: A review of methods. Pharma Forum, 25:8298–305.
  • Dhawan S, Varma M, Sinha VR. (2005). High molecular weight poly(ethylene oxide) based drug delivery systems. Part I: Hydrogels and hydrophilic systems. Pharm Technol, 29:72–80.
  • Needleman IG, Martin GP, Smales FC. (1998). Characterisation of bioadhesives for periodontal and oral mucosal drug delivery. J Clin Periodontol, 25:74–82.
  • Dhawan S, Singla AK. (2004). Composition and method for maintaining blood glucose level. US patent 6,703,045.
  • Dhawan S, Dhawan K, Varma M, Sinha VR. (2005). High molecular weight poly(ethylene oxide). Part II: Applications to drug delivery systems. Pharm Technol, 29:82–96.
  • Dhawan S, Singla AK. (2008). A method of maintaining blood glucose level by employing the hydrophilic matrix based oral controlled release antidiabetic composition. Indian patent IN212066.
  • Apicella A. (1992). Poly(ethylene oxide) (PEO) and different molecular weight PEO blend monolithic devices for drug release. Congr Int Tecnol Pharm, 4:15–24.
  • Park SJ, Kim KS, Kim SH. (2005). Effect of poly(ethylene oxide) on the release behaviors of poly(epsilon-caprolactone) microcapsules containing erythromycin. Colloids Surf B Biointerfaces, 43:238–44.
  • Varma M, Singla AK, Dhawan S. (2004). Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol. Drug Dev Ind Pharm, 30:545–53.
  • Talukder R, Fassihi R. (2004). Gastroretentive delivery systems: A mini review. Drug Dev Ind Pharm, 30:1019–28.
  • Rouge N, Buri P, Doelker E. (1996). Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm, 136:117–39.
  • Matharu RS, Sanghavi NM. (1992). Novel drug delivery system for captopril. Drug Dev Ind Pharm, 18:1567–74.
  • Fell JT. (1996). Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract. J Anat, 189:517–9.
  • Rocca JG, Omidian H, Shah K. (2003). Progresses in gastroretentive drug delivery systems. Drug Deliv (Oral) Business Briefing, Pharm Tech, 152–156.
  • Hwang SJ, Park H, Park K. (1998). Gastric retentive drug-delivery systems. Crit Rev Ther Drug Carrier Syst, 15:243–84.
  • USP. (2004). United States Pharmacopoeia. Rockwille, MD: The United States Pharmacopoeial Convention, Inc.
  • Kumar V, de la Luz Reus-Medina M, Yang D. (2002). Preparation, characterization, and tabletting properties of a new cellulose-based pharmaceutical aid. Int J Pharm, 235:129–40.
  • Carr RL. (1965). Evaluation of flow properties of solids. Chem Eng, 72:163–8.
  • Schroder K, Schmid K, Lobenberg R. (2007). Influence of bulk and tapped density on the determination of the thermal conductivity of powders and blends. AAPS PharmSciTech, 8:E78.
  • Shah RB, Tawakkul MA, Khan MA. (2008). Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech, 9:250–8. Epub 2008 Feb 2015.
  • Chrzanowski F. (2008). Preformulation considerations for controlled release dosage forms. Part I. Selecting candidates. AAPS PharmSciTech, 9:635–8.
  • Talukdar MM, Kinget R. (1995). Swelling and drug release behaviour of xanthum gum matrix tablets. Int J Pharm, 120:63–72.
  • Lachman L, Lieberman HA, Kanig JL. (1991). The theory and practice of industrial pharmacy. 3rd ed. Bombay: Varghese Publishing House, Hind Rajasthan Building, Dadar.
  • Young PM, Edge S, Staniforth JN, Steele DF, Traini D, Price R. (2007). Effect of moisture on the compressibility and compactibility of sodium starch glycolate. Pharm Dev Technol, 12:217–22.
  • Bravo-Osuna I, Ferrero C, Jimenez-Castellanos MR. (2007). Influence of moisture content on the mechanical properties of methyl methacrylate-starch copolymers. Eur J Pharm Biopharm, 66:63–72.
  • Kaerger JS, Edge S, Price R. (2004). Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. Eur J Pharm Sci, 22:173–9.
  • Picker-Freyer KM, Durig T. (2007). Physical mechanical and tablet formation properties of hydroxypropylcellulose: In pure form and in mixtures. AAPS PharmSciTech, 8:E92.
  • Uribarri E, Laguna A, Sierra R, Ricardo Y. (2002). Physico-mechanical characterization of policosanol, a novel hypocholesterolemic drug. Drug Dev Ind Pharm, 28:89–93.
  • Patel VM, Prajapati BG, Patel HV, Patel KM. (2007). Mucoadhesive bilayer tablets of propranolol hydrochloride. AAPS PharmSciTech, 8:E77.
  • Patel VM, Prajapati BG, Patel MM. (2007). Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech, 8:22.
  • Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2003). Mucoadhesive buccal patches of miconazole nitrate: In vitro/in vivo performance and effect of ageing. Int J Pharm, 264:1–14.
  • Nafee NA, Ismail FA, Boraie NA, Mortada LM. (2004). Mucoadhesive delivery systems. II. Formulation and in-vitro/in-vivo evaluation of buccal mucoadhesive tablets containing water-soluble drugs. Drug Dev Ind Pharm, 30:995–1004.
  • Adhikary A, Vavia PR. (2008). Bioadhesive ranitidine hydrochloride for gastroretention with controlled microenvironmental pH. Drug Dev Ind Pharm, 34:860–9.
  • Singh B, Pahuja S, Kapil R, Ahuja N. (2009). Formulation development of oral controlled release tablets of hydralazine: Optimization of drug release and bioadhesive characteristics. Acta Pharm, 59:1–13.
  • Singh B, Chakkal SK, Ahuja N. (2006). Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS PharmSciTech, 7:E1–10.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.